Compare WEX & NVST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WEX | NVST |
|---|---|---|
| Founded | 1983 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.8B | 4.8B |
| IPO Year | 2004 | 2019 |
| Metric | WEX | NVST |
|---|---|---|
| Price | $151.40 | $29.25 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 10 | 14 |
| Target Price | ★ $164.60 | $24.85 |
| AVG Volume (30 Days) | 516.3K | ★ 3.4M |
| Earning Date | 05-04-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 12.93 | ★ 104.31 |
| EPS | ★ 8.47 | 0.28 |
| Revenue | ★ $2,660,800,000.00 | $2,566,500,000.00 |
| Revenue This Year | $3.69 | $6.67 |
| Revenue Next Year | $5.15 | $3.52 |
| P/E Ratio | ★ $17.71 | $105.68 |
| Revenue Growth | ★ 1.24 | N/A |
| 52 Week Low | $110.45 | $14.22 |
| 52 Week High | $180.71 | $30.42 |
| Indicator | WEX | NVST |
|---|---|---|
| Relative Strength Index (RSI) | 46.18 | 65.55 |
| Support Level | $144.92 | $19.41 |
| Resistance Level | $156.32 | $30.42 |
| Average True Range (ATR) | 6.34 | 1.04 |
| MACD | -0.87 | -0.02 |
| Stochastic Oscillator | 16.79 | 68.21 |
WEX Inc is a provider of corporate payment solutions. The company operates three business segments: Mobility, Benefits, and Corporate Payments. Mobility segment, the top segment by revenue, provides fleet vehicle payment solutions, transaction processing, and information management services for commercial and government fleets. The Corporate Payments segment offers business-to-business payment processing and transaction monitoring services. The Benefits segment generates revenue from healthcare payment products and its consumer-directed software platform. The company's prime end market is the United States of America.
Envista Holdings Corp is a dental products company. It develops, manufactures, and markets portfolios of dental consumables, equipment, and services to dental professionals. The company's business consists of two segments; Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment, which derives key revenue, develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics, and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. Geographically, the company generates a majority of its revenue from North America, followed by Western Europe and other developed and emerging markets.